Header Logo

Connection

Judith James to Adult

Back to Details
This is a "connection" page, showing publications Judith James has written about Adult.
Judith James
Connection Strength
2.405
Adult
  1. Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment. Arthritis Care Res (Hoboken). 2026 Apr; 78(4):520-527.
    View in: PubMed
    Score: 0.100
  2. Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity. Lupus Sci Med. 2025 Nov 28; 12(2).
    View in: PubMed
    Score: 0.100
  3. Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. Lancet Rheumatol. 2024 Mar; 6(3):e168-e177.
    View in: PubMed
    Score: 0.088
  4. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype. J Allergy Clin Immunol. 2020 12; 146(6):1419-1433.
    View in: PubMed
    Score: 0.068
  5. Unique Sjögren's syndrome patient subsets defined by molecular features. Rheumatology (Oxford). 2020 04 01; 59(4):860-868.
    View in: PubMed
    Score: 0.068
  6. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. J Autoimmun. 2020 01; 106:102332.
    View in: PubMed
    Score: 0.065
  7. Immunologic findings precede rapid lupus flare after transient steroid therapy. Sci Rep. 2019 06 13; 9(1):8590.
    View in: PubMed
    Score: 0.064
  8. Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients. EBioMedicine. 2019 Apr; 42:76-85.
    View in: PubMed
    Score: 0.063
  9. Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes. Front Immunol. 2018; 9:2198.
    View in: PubMed
    Score: 0.061
  10. Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls. Arthritis Care Res (Hoboken). 2017 12; 69(12):1780-1788.
    View in: PubMed
    Score: 0.057
  11. Pathways of impending disease flare in African-American systemic lupus erythematosus patients. J Autoimmun. 2017 03; 78:70-78.
    View in: PubMed
    Score: 0.054
  12. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity. Arthritis Rheumatol. 2016 10; 68(10):2492-502.
    View in: PubMed
    Score: 0.053
  13. Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination. Clin Vaccine Immunol. 2016 08; 23(8):664-71.
    View in: PubMed
    Score: 0.052
  14. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification. Ann Rheum Dis. 2016 Nov; 75(11):2014-2021.
    View in: PubMed
    Score: 0.051
  15. Barriers And Motivators for Smoking Cessation in Patients With Systemic Lupus Erythematosus (SLE). J Okla State Med Assoc. 2015 Nov; 108(11):492-9.
    View in: PubMed
    Score: 0.050
  16. Humoral responses to independent vaccinations are correlated in healthy boosted adults. Vaccine. 2014 Sep 29; 32(43):5624-31.
    View in: PubMed
    Score: 0.046
  17. Protective antigen-specific memory B cells persist years after anthrax vaccination and correlate with humoral immunity. Toxins (Basel). 2014 Aug 13; 6(8):2424-31.
    View in: PubMed
    Score: 0.046
  18. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare. Arthritis Rheumatol. 2014 Jul; 66(7):1888-99.
    View in: PubMed
    Score: 0.045
  19. Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls. PLoS One. 2014; 9(4):e94500.
    View in: PubMed
    Score: 0.045
  20. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum. 2012 Nov; 64(11):3677-86.
    View in: PubMed
    Score: 0.040
  21. Rheumatic disease among Oklahoma tribal populations: a cross-sectional study. J Rheumatol. 2012 Oct; 39(10):1934-41.
    View in: PubMed
    Score: 0.040
  22. B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis Rheum. 2011 Dec; 63(12):3931-41.
    View in: PubMed
    Score: 0.038
  23. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 2011 Aug; 63(8):2396-406.
    View in: PubMed
    Score: 0.037
  24. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. Vaccine. 2011 May 09; 29(20):3670-8.
    View in: PubMed
    Score: 0.036
  25. Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis. Clin Exp Immunol. 2010 Nov; 162(2):262-70.
    View in: PubMed
    Score: 0.035
  26. Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. J Infect Dis. 2010 Jul 15; 202(2):251-60.
    View in: PubMed
    Score: 0.034
  27. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. J Mol Med (Berl). 2010 Jul; 88(7):719-27.
    View in: PubMed
    Score: 0.034
  28. Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus. Arthritis Rheum. 2009 Mar; 60(3):848-59.
    View in: PubMed
    Score: 0.031
  29. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev. 2009 Feb; 8(4):337-42.
    View in: PubMed
    Score: 0.031
  30. Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. J Autoimmun. 2006 Dec; 27(4):272-80.
    View in: PubMed
    Score: 0.027
  31. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus. 2007; 16(6):401-9.
    View in: PubMed
    Score: 0.027
  32. Identification of Sj?gren's disease-associated T cell receptor motifs through deep sequencing. JCI Insight. 2025 Dec 22; 10(24).
    View in: PubMed
    Score: 0.025
  33. IgA2+ B cells and IgA2 anti-dsDNA antibodies are selectively targeted by belimumab after rituximab therapy in systemic lupus erythematosus. Cell Rep Med. 2025 Aug 19; 6(8):102247.
    View in: PubMed
    Score: 0.024
  34. Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis. J Clin Invest. 2025 Aug 15; 135(16).
    View in: PubMed
    Score: 0.024
  35. Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. J Clin Invest. 2025 Mar 17; 135(6).
    View in: PubMed
    Score: 0.024
  36. Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages. Ann Rheum Dis. 2025 Feb; 84(2):294-306.
    View in: PubMed
    Score: 0.023
  37. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum. 2004 Apr; 50(4):1226-32.
    View in: PubMed
    Score: 0.022
  38. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLoS One. 2023; 18(6):e0286297.
    View in: PubMed
    Score: 0.021
  39. Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J Immunol. 2002 Feb 15; 168(4):2054-62.
    View in: PubMed
    Score: 0.019
  40. Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B'. Biochem Biophys Res Commun. 2001 Aug 03; 285(5):1206-12.
    View in: PubMed
    Score: 0.019
  41. Increased cognitive workload evokes greater neurovascular coupling responses in healthy young adults. PLoS One. 2021; 16(5):e0250043.
    View in: PubMed
    Score: 0.018
  42. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 2001 May; 44(5):1122-6.
    View in: PubMed
    Score: 0.018
  43. TLR engagement induces ARID3a in human blood hematopoietic progenitors and modulates IFNa production. Cell Immunol. 2020 11; 357:104201.
    View in: PubMed
    Score: 0.017
  44. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies. JCI Insight. 2020 08 20; 5(16).
    View in: PubMed
    Score: 0.017
  45. Associations between daily alcohol consumption and systemic lupus erythematosus-related cytokines and chemokines among US female nurses without SLE. Lupus. 2020 Jul; 29(8):976-982.
    View in: PubMed
    Score: 0.017
  46. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes. PLoS One. 2020; 15(4):e0230782.
    View in: PubMed
    Score: 0.017
  47. Cell-bound complement activation products associate with lupus severity in SLE. Lupus Sci Med. 2020 04; 7(1).
    View in: PubMed
    Score: 0.017
  48. Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. Lupus Sci Med. 2020; 7(1):e000360.
    View in: PubMed
    Score: 0.017
  49. Mock Recruitment for the Study of Antimalarials in an Incomplete Lupus Erythematosus Trial. Arthritis Care Res (Hoboken). 2019 11; 71(11):1425-1429.
    View in: PubMed
    Score: 0.016
  50. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight. 2019 10 17; 4(20).
    View in: PubMed
    Score: 0.016
  51. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial. Trials. 2018 Dec 20; 19(1):694.
    View in: PubMed
    Score: 0.015
  52. ARID3a gene profiles are strongly associated with human interferon alpha production. J Autoimmun. 2019 01; 96:158-167.
    View in: PubMed
    Score: 0.015
  53. A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif. J Autoimmun. 1998 Oct; 11(5):431-8.
    View in: PubMed
    Score: 0.015
  54. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 09; 70(9):1470-1480.
    View in: PubMed
    Score: 0.015
  55. Evidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N-Glycosylation in Antibody-Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren's Syndrome. Arthritis Rheumatol. 2018 07; 70(7):1102-1113.
    View in: PubMed
    Score: 0.015
  56. Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21-/low B Cells From Patients With Sjögren's Syndrome. Arthritis Rheumatol. 2018 02; 70(2):298-307.
    View in: PubMed
    Score: 0.014
  57. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest. 1997 Dec 15; 100(12):3019-26.
    View in: PubMed
    Score: 0.014
  58. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients. Clin Vaccine Immunol. 2017 Nov; 24(11).
    View in: PubMed
    Score: 0.014
  59. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study. Neurology. 2017 Sep 26; 89(13):1330-1337.
    View in: PubMed
    Score: 0.014
  60. The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials. Arthritis Rheumatol. 2017 06; 69(6):1257-1266.
    View in: PubMed
    Score: 0.014
  61. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated. Vaccine. 2017 06 08; 35(26):3416-3422.
    View in: PubMed
    Score: 0.014
  62. Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis. PLoS One. 2017; 12(2):e0171193.
    View in: PubMed
    Score: 0.014
  63. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death. Clin Immunol. 2017 12; 185:3-9.
    View in: PubMed
    Score: 0.013
  64. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Res Ther. 2016 09 02; 18:197.
    View in: PubMed
    Score: 0.013
  65. Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus. Ann Rheum Dis. 2017 Jan; 76(1):153-158.
    View in: PubMed
    Score: 0.013
  66. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614.
    View in: PubMed
    Score: 0.012
  67. Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells. J Immunol. 2015 Feb 01; 194(3):940-9.
    View in: PubMed
    Score: 0.012
  68. Disease activity in systemic lupus erythematosus correlates with expression of the transcription factor AT-rich-interactive domain 3A. Arthritis Rheumatol. 2014 Dec; 66(12):3404-12.
    View in: PubMed
    Score: 0.012
  69. Antibody-secreting cell specificity in labial salivary glands reflects the clinical presentation and serology in patients with Sjögren's syndrome. Arthritis Rheumatol. 2014 Dec; 66(12):3445-56.
    View in: PubMed
    Score: 0.012
  70. Association of systemic lupus erythematosus with uranium exposure in a community living near a uranium-processing plant: a nested case-control study. Arthritis Rheumatol. 2014 Nov; 66(11):3105-12.
    View in: PubMed
    Score: 0.012
  71. Genome-wide DNA methylation study identifies significant epigenomic changes in osteoarthritic cartilage. Arthritis Rheumatol. 2014 Oct; 66(10):2804-15.
    View in: PubMed
    Score: 0.012
  72. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis. 2016 Jan; 75(1):242-52.
    View in: PubMed
    Score: 0.011
  73. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014 Feb; 66(2):390-6.
    View in: PubMed
    Score: 0.011
  74. Familial aggregation of high tumor necrosis factor alpha levels in systemic lupus erythematosus. Clin Dev Immunol. 2013; 2013:267430.
    View in: PubMed
    Score: 0.011
  75. Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry. J Rheumatol. 2013 Jun; 40(6):842-9.
    View in: PubMed
    Score: 0.010
  76. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet. 2013 Jun; 45(6):664-9.
    View in: PubMed
    Score: 0.010
  77. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum. 2012 Nov; 64(11):3687-94.
    View in: PubMed
    Score: 0.010
  78. Large-scale analysis of tumor necrosis factor a levels in systemic lupus erythematosus. Arthritis Rheum. 2012 Sep; 64(9):2947-52.
    View in: PubMed
    Score: 0.010
  79. Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis Rheum. 2012 Feb; 64(2):485-92.
    View in: PubMed
    Score: 0.010
  80. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum. 2011 Sep; 63(9):2755-63.
    View in: PubMed
    Score: 0.009
  81. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011 Aug; 121(8):3109-19.
    View in: PubMed
    Score: 0.009
  82. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. 2011 Oct; 70(10):1752-7.
    View in: PubMed
    Score: 0.009
  83. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53.
    View in: PubMed
    Score: 0.009
  84. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins. Mult Scler. 2010 Dec; 16(12):1527-8.
    View in: PubMed
    Score: 0.009
  85. Patients with familial and sporadic onset SLE have similar clinical profiles but vary profoundly by race. Lupus. 2008 Nov; 17(11):1004-9.
    View in: PubMed
    Score: 0.008
  86. Autoantibody prevalence and lupus characteristics in a unique African American population. Arthritis Rheum. 2008 May; 58(5):1237-47.
    View in: PubMed
    Score: 0.007
  87. Autoimmunity as a result of escape from RNA surveillance. J Immunol. 2006 Aug 01; 177(3):1698-707.
    View in: PubMed
    Score: 0.007
  88. Systemic lupus erythematosus (SLE) and chromosome 16: confirmation of linkage to 16q12-13 and evidence for genetic heterogeneity. Eur J Hum Genet. 2004 Aug; 12(8):668-72.
    View in: PubMed
    Score: 0.006
  89. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum. 1999 Jan; 42(1):69-75.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.